½ÃÀ庸°í¼­
»óǰÄÚµå
1298775

Á¤½Å°Ç°­¿ë ½Å±Ô ±â±â ¹× Ç÷§Æû ½ÃÀå : À¯Çüº°, ¿ëµµº°, Áö¿ªº°(2023-2028³â)

Emerging Mental Health Devices and Platforms Market by Type (Platforms, Devices), Application (Stress, Anxiety, Depression, Bipolar Disorder, and Others), and Region 2023-2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 144 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è Á¤½Å°Ç°­¿ë ½Å±Ô ±â±â ¹× Ç÷§Æû ½ÃÀå ±Ô¸ð´Â 2022³â 30¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. IMARC GroupÀº 2023³âºÎÅÍ 2028³â±îÁö ÀÌ ½ÃÀåÀÌ 24.35%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸À̸ç 2028³â±îÁö 114¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. ´Ù¾çÇÑ Á¤½Å °Ç°­ ÁúȯÀÇ À¯º´·ü Áõ°¡, Á¤½Å °Ç°­ ¹× Àü¹ÝÀûÀÎ À£ºù¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, °³º°È­µÈ °³ÀÔÀ» À§ÇÑ Á¤½Å °Ç°­ ±â±â ¹× Ç÷§Æû¿¡ ÷´Ü ±â¼úÀÇ ÅëÇÕÀº ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù.

Á¤½Å°Ç°­¿ë ½Å±Ô ±â±â ¹× Ç÷§ÆûÀº ¼¾¼­, ¿þ¾î·¯ºí, ¸ð¹ÙÀÏ ¾Û µî ´Ù¾çÇÑ ±â¼úÀ» Ȱ¿ëÇØ Á¢±Ù¼ºÀÌ ³ô°í °³ÀÎÈ­µÈ Á¤½Å °Ç°­ °ü¸® ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ÇコÄÉ¾î ¼Ö·ç¼ÇÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº µ¥ÀÌÅÍ ºÐ¼®, ¸Ó½Å·¯´×, ½Ç½Ã°£ ¸ð´ÏÅ͸µÀ» Ȱ¿ëÇÏ¿© Áø´Ü Á¤È®µµ¸¦ ³ôÀ̰í Ä¡·á °èȹÀ» ¼ö¸³ÇÕ´Ï´Ù. ¶ÇÇÑ ¸¹Àº Á¤½Å Áúȯ¿¡ ´ëÇØ ºñ¿ë È¿À²ÀûÀÌ°í Æí¸®ÇÑ Ä¡·á ¿É¼ÇÀ» Á¦°øÇϰí, Á¤½ÅÀû Áö¿øÀÌ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô °¡»ó Áö¿ø ¹× ¿Â¶óÀÎ »ó´ãÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, Á¤º¸¸¦ ¼öÁýÇÏ°í °³ÀÎÀÇ Á¤½Å °Ç°­ »óŸ¦ Æò°¡ÇÏ¿© Á¤½Å °Ç°­ À§±â¸¦ ¿¹¹æÇÒ ¼ö ÀÖ´Â Á¶±â ¹ß°ß°ú °³ÀÔÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ±â¼úÀº ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¸¦ Áö¿øÇÏ¿© ¿ø°Ý Áø·á ¹× ¿ø°Ý Ä¡·á¸¦ Á¦°øÇÔÀ¸·Î½á ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ »ç¶÷µéÀÇ Á¤½Å °Ç°­ °ü¸®¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. »õ·Î¿î Á¤½Å °Ç°­ ±â±â ¹× Ç÷§ÆûÀÇ ÀåÁ¡Àº °³ÀÎÈ­µÇ°í ±â¹Ð¼ºÀÌ ³ôÀº Á¤½Å °Ç°­ °ü¸® ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© Á¤½Å °Ç°­ À§±â¸¦ ¿¹¹æÇÏ°í °ªºñ½Ñ ¸é´ã ¿¹¾àÀÇ Çʿ伺À» ÁÙÀÏ ¼ö ÀÖ´Ù´Â °ÍÀÔ´Ï´Ù. ±× °á°ú ºÒ¾È°ú ½ºÆ®·¹½º °ü¸®, ¿ì¿ïÁõ Ä¡·á, Áßµ¶ ȸº¹¿¡ ³Î¸® Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù.

Á¤½Å°Ç°­¿ë ½Å±Ô ±â±â ¹× Ç÷§Æû ½ÃÀå µ¿Çâ:

¼¼°è ½ÃÀåÀº ÁÖ·Î ¿ì¿ïÁõ, ºÒ¾È Àå¾Ö, ¿Ü»ó ÈÄ ½ºÆ®·¹½º Àå¾Ö(PTSD)¿Í °°Àº ´Ù¾çÇÑ Á¤½Å °Ç°­ Àå¾ÖÀÇ À¯º´·ü Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ½ºÆ®·¹½º ¼öÁØ Áõ°¡¿Í ÇÔ²² ´ëÁßÀÇ ¹Ù»Û »ýȰ ¹æ½Ä¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ¿¡ µû¶ó Á¤½Å°Ç°­°ú Àü¹ÝÀûÀÎ À£ºù¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Á¢±ÙÀÌ ¿ëÀÌÇϰí Àú·ÅÇÏ¸ç Æí¸®ÇÑ Á¤½Å°Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀΰøÁö´É(AI), ¸Ó½Å·¯´×(ML), °¡»óÇö½Ç(VR)°ú °°Àº ÷´Ü ±â¼úÀÌ °³ÀÎ ¸ÂÃãÇü °³ÀÔÀ» À§ÇÑ Á¤½Å°Ç°­ ±â±â ¹× Ç÷§Æû¿¡ ÅëÇյǰí ÀÖ´Â °Íµµ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. Á¤½Å°Ç°­ ¼­ºñ½º¿¡ ´ëÇÑ ¿ø°Ý Á¢±ÙÀ» ¿ëÀÌÇÏ°Ô Çϱâ À§ÇÑ ¿ø°Ý ÀÇ·á ¼­ºñ½ºÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀåÀÇ Áß¿äÇÑ ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿©·¯ ±¹°¡ÀÇ Á¤ºÎ ¹× ¹Î°£ ±â°ü¿¡¼­ Á¤½Å °Ç°­¿¡ ´ëÇÑ ³ë·Â°ú ÇÁ·Î±×·¥¿¡ ´ëÇÑ ÅõÀÚ°¡ Å©°Ô Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. À̿ʹ º°°³·Î Á¤½Å °Ç°­ °ü·Ã ½ºÅ¸Æ®¾÷ Áõ°¡µµ ½ÃÀå Àü¸ÁÀ» ¹à°Ô Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤½Å°Ç°­¿ë ±â±â ¹× Ç÷§ÆûÀÌ ÀÇ·á ½Ã½ºÅÛ°ú ÅëÇյǰí, Á¤½Å°Ç°­À» ÅëÇÕÇÑ »õ·Î¿î Á¾ÇÕ °Ç°­ °ü¸® °èȹÀÌ µµÀԵǸ鼭 ½ÃÀåÀ» Ȱ¼ºÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ Á¤½Å°Ç°­¿¡ ´ëÇÑ Æí°ßÀÇ °¨¼Ò, ±Þ¼ÓÇÑ µµ½ÃÈ­, Á÷Àå ³» Á¤½Å°Ç°­ ´ëÃ¥ÀÇ ´ëÆøÀûÀÎ ¼ºÀå, ±¤¹üÀ§ÇÑ ¿¬±¸°³¹ß(R&D) Ȱµ¿ µîÀÌ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÏ´Â ¿äÀÎÀÔ´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®µé

  • ¼¼°è Á¤½Å°Ç°­¿ë ½Å±Ô ±â±â ¹× Ç÷§Æû ½ÃÀåÀº Áö±Ý±îÁö ¾î¶»°Ô ¼ºÀåÇØ¿ÔÀ¸¸ç, ÇâÈÄ ¸î ³â µ¿¾È ¾î¶»°Ô ¼ºÀåÇÒ °ÍÀΰ¡?
  • ¼¼°è Á¤½Å°Ç°­¿ë ½Å±Ô ±â±â ¹× Ç÷§Æû ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ ¹× ±âȸ´Â?
  • ¼¼°è Á¤½Å°Ç°­¿ë ½Å±Ô ±â±â ¹× Ç÷§Æû ½ÃÀå¿¡ ¹ÌÄ¡´Â °¢ ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ°¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • ÁÖ¿ä Áö¿ª ½ÃÀåÀº?
  • °¡Àå ¸Å·ÂÀûÀÎ Á¤½Å °Ç°­ ½Å±Ô ±â±â ¹× Ç÷§Æû ½ÃÀåÀ» ´ëÇ¥ÇÏ´Â ±¹°¡´Â ¾îµðÀΰ¡?
  • À¯Çüº° ½ÃÀå ºÐ¼®Àº?
  • Á¤½Å°Ç°­¿ë ½Å±Ô ±â±â ¹× Ç÷§Æû ½ÃÀå¿¡¼­ °¡Àå ¸Å·ÂÀûÀÎ À¯ÇüÀº?
  • ¿ëµµº° ½ÃÀå ºÐ¼®Àº?
  • Á¤½Å°Ç°­¿ë ½Å±Ô ±â±â ¹× Ç÷§Æû ½ÃÀå¿¡¼­ °¡Àå ¸Å·ÂÀûÀÎ ¿ëµµ´Â?
  • ¼¼°è Á¤½Å°Ç°­¿ë ½Å±Ô ±â±â ¹× Ç÷§Æû ½ÃÀå °æÀï ±¸µµ´Â?
  • ¼¼°è Á¤½Å°Ç°­¿ë ½Å±Ô ±â±â ¹× Ç÷§Æû ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ Á¢±Ù
    • Åé´Ù¿î Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä »ê¾÷ µ¿Çâ

Á¦5Àå ¼¼°èÀÇ Á¤½Å°Ç°­¿ë ½Å±Ô ±â±â ¹× Ç÷§Æû ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : À¯Çüº°

  • Ç÷§Æû
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • µð¹ÙÀ̽º
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • EEG ¹× ECG Çìµå ¹êµå
      • ¿þ¾î·¯ºí Æ®·¡Ä¿
      • ±âŸ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ½ºÆ®·¹½º
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ºÒ¾È
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¿ì¿ïÁõ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Á¶¿ïÁõ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ij³ª´Ù
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ÀϺ»
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Àεµ ½ÃÀå
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Çѱ¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • È£ÁÖ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Àεµ³×½Ã¾Æ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ±âŸ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • À¯·´
    • µ¶ÀÏ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ÇÁ¶û½º
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ¿µ±¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ÀÌÅ»¸®¾Æ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ½ºÆäÀÎ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ·¯½Ã¾Æ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ±âŸ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ¸ß½ÃÄÚ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ±âŸ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀΰú ±âȸ

  • ½ÃÀå °³¿ä
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ

Á¦10Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦11Àå PorterÀÇ Five Forces ºÐ¼®

  • °³¿ä
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦12Àå °¡°Ý ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • AbleTo Inc.
    • Amelia Virtual Care
    • Clarigent Corporation
    • Electromedical Products International Inc
    • Feel Therapeutics
    • Flow Neuroscience
    • Happify Inc.
    • Headspace Inc.
    • Pear Therapeutics, Inc.
    • Quartet Health Inc.
    • Talkspace Inc.
    • Teladoc Health Inc.
    • Woebot Labs, Inc.

º» º¸°í¼­¿¡ ±âÀçµÇ¾î ÀÖ´Â ±â¾÷ ¸®½ºÆ®´Â ÀϺÎÀ̸ç, ¿ÏÀüÇÑ ¸®½ºÆ®´Â º» º¸°í¼­¿¡ ±âÀçµÇ¾î ÀÖ½À´Ï´Ù.

LSH 23.07.11

The global emerging mental health devices and platforms market size reached US$ 3.02 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.44 Billion by 2028, exhibiting a growth rate (CAGR) of 24.35% during 2023-2028. The increasing prevalence of numerous mental health disorders, the growing awareness regarding mental health and its impact on overall well-being, and the incorporation of advanced technologies in mental health devices and platforms for personalized interventions represent some of the key factors driving the market.

Emerging mental health devices and platforms are healthcare solutions that provide accessible and personalized mental health care solutions using various technologies, such as sensors, wearables, and mobile apps. These systems leverage data analytics, machine learning, and real-time monitoring to improve diagnosis accuracy and curate treatment plans. They also offer cost-effective and convenient treatment options for numerous mental disorders and provide virtual assistance and online consultations to patients in need of mental support. Additionally, they collect information and assess the mental health status of an individual, which provides early detection and intervention to prevent mental health crises. Additionally, these technologies can assist healthcare providers in providing remote care and teletherapy to improve access to mental health care for underserved populations. Some of the advantages of emerging mental health devices and platforms include personalized and confidential mental health care solutions that can prevent mental health crises and reduce the need for expensive in-person appointments. As a result, they are extensively utilized in anxiety and stress management, depression treatment, and addiction recovery applications.

Emerging Mental Health Devices and Platforms Market Trends:

The global market is primarily driven by the increasing prevalence of numerous mental health disorders, such as depression, anxiety, and post-traumatic stress disorder (PTSD). This can be attributed to the hectic lifestyle of the masses along with the rising levels of stress. In line with this, the growing awareness regarding mental health and its impact on overall well-being is propelling the demand for accessible, affordable and convenient mental health solutions, which, in turn, is driving the market. Moreover, the incorporation of advanced technologies such as artificial intelligence (AI), machine learning (ML), and virtual reality (VR) in mental health devices and platforms for personalized interventions is impacting the market positively. The increasing adoption of telemedicine services for facilitating remote access to mental health services is also acting as a significant growth-inducing factor for the market. The market is further driven by the considerable rise in investments in mental health initiatives and programs by government bodies and private agencies of multiple countries. Apart from this, the increasing number of mental health startups is creating a positive outlook for the market. Furthermore, the integration of mental health devices and platforms with healthcare systems along with the introduction of new overall healthcare plans that incorporate mental health is fueling the market. Some of the other factors contributing to the market include reduced stigma for mental health, rapid urbanization, considerable growth in workplace mental health initiatives, and extensive research and development (R&D) activities.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global emerging mental health devices and platforms market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on type and application.

Type Insights:

Platforms

Devices

EEG and ECG head bands

Wearable Trackers

Others

The report has provided a detailed breakup and analysis of the emerging mental health devices and platforms market based on the type. This includes platforms and devices (EEG and ECG head bands, wearable trackers, and others). According to the report, platforms represented the largest segment.

Application Insights:

Stress

Anxiety

Depression

Bipolar Disorder

Others

A detailed breakup and analysis of the emerging mental health devices and platforms market based on the application has also been provided in the report. This includes stress, anxiety, depression, bipolar disorder, and others. According to the report, depression accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for emerging mental health devices and platforms. Some of the factors driving the North America emerging mental health devices and platforms market included continual technological advancements, rising demand for personalized mental health interventions, high healthcare expenditure, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global emerging mental health devices and platforms market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AbleTo Inc., Amelia Virtual Care, Clarigent Corporation, Electromedical Products International Inc, Feel Therapeutics, Flow Neuroscience, Happify Inc., Headspace Inc., Pear Therapeutics, Inc., Quartet Health Inc., Talkspace Inc., Teladoc Health Inc., Woebot Labs, Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global emerging mental health devices and platforms market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global emerging mental health devices and platforms market?
  • What is the impact of each driver, restraint, and opportunity on the global emerging mental health devices and platforms market?
  • What are the key regional markets?
  • Which countries represent the most attractive emerging mental health devices and platforms market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the emerging mental health devices and platforms market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the emerging mental health devices and platforms market?
  • What is the competitive structure of the global emerging mental health devices and platforms market?
  • Who are the key players/companies in the global emerging mental health devices and platforms market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Emerging Mental Health Devices and Platforms Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Platforms
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 EEG and ECG head bands
      • 6.2.2.2 Wearable Trackers
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Stress
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Anxiety
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Depression
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Bipolar Disorder
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AbleTo Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Amelia Virtual Care
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Clarigent Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Electromedical Products International Inc
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Feel Therapeutics
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Flow Neuroscience
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Happify Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Headspace Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Pear Therapeutics, Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Quartet Health Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Talkspace Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 Teladoc Health Inc.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
    • 13.3.13 Woebot Labs, Inc.
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦